Warning: Illegal string offset 'enable' in /home/redhothe/public_html/wp-content/plugins/conditional-widgets/logic.php on line 171
RED HOT Contributors


Advent Access wins CE Mark for dialysis device

CREDIT: This post was originally published on this site

The av-Guardian vascular access system designed for hemodialysis patients. (Image from Advent Access)

Singapore-based vascular access device company Advent Access said it has received the CE Mark for its av-Guardian technology designed to create vascular access for dialysis patients.

The device-guided needling platform features the company’s “guardian guide-door” technology for accessing arteriovenous fistulas, which it claims can reduce wear and tear on the dialysis patient’s veins. The technology may be used in a dialysis center or at home, regardless of the types of dialysis machine being used, according to the company

“Receiving CE Mark approval for av-Guardian is an important milestone in our mission to provide a more comfortable treatment for patients suffering long term end-stage kidney disease and to reduce the cost burden of maintenance dialysis,” Advent Access CEO Peh Ruey Feng said in a news release. “Our focus now is to work with high-quality manufacturing and distribution partners to realize the impact we can make in potentially changing the way hemodialysis patients receive treatment either in the center or at home.”

The av-Guardian technology was recently evaluated in a first-in-human study conducted at Singapore General Hospital and National University Hospital of Singapore, with support from the National Kidney Foundation. The study was a non-randomized, prospective clinical investigation to assess the safety and clinical performance of the av-Guardian across 216 hemodialysis sessions in patients with native AV fistulas. The study showed that av-Guardian met all safety and performance endpoints, achieving 94% to 98% successful access to the AV fistula, with 86% to 90% success at the first needle attempt, according to the company.



We Support OUR Contributors

Comments are closed.

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast